Cargando…
Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453921/ https://www.ncbi.nlm.nih.gov/pubmed/28421455 http://dx.doi.org/10.1007/s13555-017-0179-0 |
| _version_ | 1783240736005685248 |
|---|---|
| author | Stockfleth, Eggert von Kiedrowski, Ralph Dominicus, Rolf Ryan, John Ellery, Adam Falqués, Meritxell Ivanoff, Nathalie Azeredo, Rosario Rodriguez |
| author_facet | Stockfleth, Eggert von Kiedrowski, Ralph Dominicus, Rolf Ryan, John Ellery, Adam Falqués, Meritxell Ivanoff, Nathalie Azeredo, Rosario Rodriguez |
| author_sort | Stockfleth, Eggert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5453921 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54539212017-06-16 Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial Stockfleth, Eggert von Kiedrowski, Ralph Dominicus, Rolf Ryan, John Ellery, Adam Falqués, Meritxell Ivanoff, Nathalie Azeredo, Rosario Rodriguez Dermatol Ther (Heidelb) Erratum Springer Healthcare 2017-04-18 /pmc/articles/PMC5453921/ /pubmed/28421455 http://dx.doi.org/10.1007/s13555-017-0179-0 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Erratum Stockfleth, Eggert von Kiedrowski, Ralph Dominicus, Rolf Ryan, John Ellery, Adam Falqués, Meritxell Ivanoff, Nathalie Azeredo, Rosario Rodriguez Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title | Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title_full | Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title_fullStr | Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title_full_unstemmed | Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title_short | Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial |
| title_sort | erratum to: efficacy and safety of 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of actinic keratosis: a phase iii, randomized, double-blind, vehicle-controlled trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453921/ https://www.ncbi.nlm.nih.gov/pubmed/28421455 http://dx.doi.org/10.1007/s13555-017-0179-0 |
| work_keys_str_mv | AT stockfletheggert erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT vonkiedrowskiralph erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT dominicusrolf erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT ryanjohn erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT elleryadam erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT falquesmeritxell erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT ivanoffnathalie erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial AT azeredorosariorodriguez erratumtoefficacyandsafetyof5fluorouracil05salicylicacid10inthefielddirectedtreatmentofactinickeratosisaphaseiiirandomizeddoubleblindvehiclecontrolledtrial |